OTS 2025 Budapest – The Future of Oligonucleotide Therapeutics
October 19 to 22, 2025
Location :
Budapest Congress Center
Budapest, Jagelló út 1-3, 1123 Hungary
Website : OTS Budapest 2025
Organizer : Oligonucleotide Therapeutics Society (OTS)
The OTS Annual Meeting brings together leading researchers and industry experts to advance the field of oligonucleotide therapeutics.
This premier event fosters collaboration and knowledge sharing, covering a wide range of topics, including antisense, siRNA, immunostimulatory, and aptamer technologies, as well as RNA/DNA editing and mRNA therapeutics. Attendees, from seasoned scientists to aspiring researchers, have the opportunity to engage in insightful discussions, present groundbreaking research, and network with peers.
The upcoming meeting will feature Adrian R. Krainer, Ph.D., St. Giles Foundation Professor at Cold Spring Harbor Laboratory and member of the CSHL Cancer Center, as the keynote speaker.
In addition, the 2025 Lifetime Achievement Award will be presented to Brett P. Monia, Ph.D., Chief Executive Officer of Ionis Pharmaceuticals.
